Duk L. Na

ORCID: 0000-0002-0098-7592
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Neurological Disease Mechanisms and Treatments
  • Functional Brain Connectivity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Cerebrovascular and Carotid Artery Diseases
  • Neurobiology of Language and Bilingualism
  • Spatial Neglect and Hemispheric Dysfunction
  • Neurological Disorders and Treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Cerebrovascular and genetic disorders
  • Mesenchymal stem cell research
  • Medical Imaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Neurogenesis and neuroplasticity mechanisms
  • Health, Environment, Cognitive Aging
  • Acute Ischemic Stroke Management
  • Parkinson's Disease Mechanisms and Treatments
  • Health and Wellbeing Research
  • Nutritional Studies and Diet
  • Cerebrospinal fluid and hydrocephalus
  • Amyotrophic Lateral Sclerosis Research
  • Diet and metabolism studies
  • EEG and Brain-Computer Interfaces
  • Stroke Rehabilitation and Recovery

Samsung Medical Center
2016-2025

Sungkyunkwan University
2016-2025

Dr Youth Clinic
2023-2025

Convergence
2023-2025

Evidence Based Research (United States)
2025

Samsung (South Korea)
2012-2023

Samsung (United Kingdom)
2016-2023

Seoul National University Hospital
2023

Korea University
2016-2021

Hallym University
2016-2021

The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool with high sensitivity for patients mild impairment (MCI). authors examined the validity and reliability of Korean version MoCA (MoCA-K) in elderly outpatients. MoCA-K, Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR) scale, neuropsychological batteries were administered to 196 persons (mild Alzheimer's disease [AD] = 44, MCI 37, normal controls [NC] 115). MoCA-K scores highly correlated those...

10.1177/0891988708316855 article EN Journal of Geriatric Psychiatry and Neurology 2008-05-12

The Seoul Neuropsychological Screening Battery (SNSB) is one of the standardized neuropsychological test batteries widely used in Korea.However, it may be a bit too lengthy for patients with decreased attention span; and does not provide score global cognitive function (GCF), which useful monitoring longitudinally.We sought to validate dementia version SNSB (SNSB-D) that was shorter than original contained only scorable tests GCF 300.We administered SNSB-D mild impairment (MCI) (n=43)...

10.3346/jkms.2010.25.7.1071 article EN cc-by-nc Journal of Korean Medical Science 2010-01-01

Noninvasive parcellation of the human cerebral cortex is an important goal for understanding and examining brain functions. Recently, patterns anatomical connections using diffusion tensor imaging (DTI) have been used to parcellate regions. Here, we present a noninvasive approach that uses "functional fingerprints" obtained by correlation measures on resting state functional magnetic resonance (fMRI) data In other terms, regions are parcellated based similarity their connection--as reflected...

10.1016/j.neuroimage.2009.10.016 article EN cc-by-nc-nd NeuroImage 2009-10-16

In Alzheimer's disease, tau pathology spreads hierarchically from the inferior temporal lobe throughout cortex, ensuing cognitive decline and dementia. Similarly, circumscribed patterns of pathological have been observed in normal ageing small vessel suggesting a spatially ordered distribution across different diseases. vitro findings suggest that may spread 'prion-like' neuronal connections an activity-dependent manner. Supporting this notion, functional brain networks show spatial...

10.1093/brain/awz026 article EN Brain 2019-02-04

Perivascular spaces that are visible on magnetic resonance imaging (MRI) a neuroimaging marker of cerebral small vessel disease. Their location may relate to the type underlying pathology: those in white matter centrum semi-ovale have been associated with amyloid angiopathy, while basal ganglia deep perforating artery arteriolosclerosis. As angiopathy is an almost invariable pathological finding Alzheimer's disease, we hypothesized MRI-visible perivascular would be clinical diagnosis whereas...

10.1093/brain/awx003 article EN Brain 2017-01-30

Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogeneous, goal of this study was use 3-dimensional MRI examine various patterns cortical atrophy that AD type, and investigate whether categorized into anatomical subtypes.

10.1212/wnl.0000000000001003 article EN Neurology 2014-10-25

Abstract Introduction We conducted a phase 1 clinical trial in nine patients with mild‐to‐moderate Alzheimer's disease to evaluate the safety and dose‐limiting toxicity of stereotactic brain injection human umbilical cord blood–derived mesenchymal stem cells (hUCB‐MSCs). Methods The low‐ (n = 3) high‐dose 6) groups received total 3.0 × 10 6 cells/60 μL 6.0 μL, respectively, into bilateral hippocampi right precuneus. Results No patient showed serious adverse events including fever during...

10.1016/j.trci.2015.06.007 article EN cc-by Alzheimer s & Dementia Translational Research & Clinical Interventions 2015-07-23

Patients with dementia develop dysphagia some time during the clinical course of their disease. The aim this study was to compare swallowing functions 2 most common types dementia: Alzheimer disease (AD) and vascular (VaD). Videofluoroscopic studies patient groups were analyzed according various oral, pharyngeal, laryngeal variables swallowing. results indicate that there are different patterns disorders. AD patients significantly more impaired in "oral transit delay over 5 seconds" liquids...

10.1097/wad.0b013e318192a539 article EN Alzheimer Disease & Associated Disorders 2009-04-01

Cerebral microbleeds (CMBs) are a neuroimaging marker of small vessel disease (SVD) with relevance for understanding mechanisms in cerebrovascular disease, cognitive impairment, and normal aging. It is hypothesized that lobar CMBs due to cerebral amyloid angiopathy (CAA) deep subcortical ischemic SVD. We tested this hypothesis using structural magnetic resonance imaging (MRI) markers SVD vivo patients impairment.We included 226 patients: 89 Alzheimer disease-related impairment (ADCI) 137...

10.1002/ana.23845 article EN Annals of Neurology 2013-01-29
Willemijn J. Jansen Rik Ossenkoppele Betty M. Tijms Anne M. Fagan Oskar Hansson and 95 more William E. Klunk Wiesje M. van der Flier Victor L. Villemagne Giovanni B. Frisoni Adam Fleisher Alberto Lleó Mark A. Mintun Anders Wallin Sebastiaan Engelborghs Duk L. Na Gaël Chételat José Luís Molinuevo Susan Landau Niklas Mattsson Johannes Kornhuber Osama Sabri Christopher C. Rowe Lucilla Parnetti Julius Popp Tormod Fladby William J. Jagust Pauline Aalten Dong Young Lee Rik Vandenberghe Catarina R. Oliveira Elisabeth Kapaki Lutz Froelich Adrian Ivanoiu Tomasz Gabryelewicz Marcel M. Verbeek Pascual Sánchez‐Juan Helmut Hildebrandt Vincent Camus Marzena Zboch David J. Brooks Alexander Drzezga Juha O. Rinne Andrew B. Newberg Alexandre de Mendonça Marie Sarazin Gil D. Rabinovici Karine Madsen Milica G. Kramberger Agneta Nordberg Vincent Mok Barbara Mroczko David A. Wolk Philipp T. Meyer Magda Tsolaki Philip Scheltens Frans R.J. Verhey Pieter Jelle Visser Dag Aarsland Daniel Alcolea M Alexander Ina S. Almdahl Steven E. Arnold Inês Baldeiras Henryk Barthel Bart N.M. van Berckel Kaj Blennow Mark A. van Buchem Enrica Cavedo Kewei Chen Elena Chipi Ann D. Cohen Stefan Förster Juan Fortea Kristian Steen Frederiksen Yvonne Freund‐Levi Olymbia Gkatzima Mark Forrest Gordon Timo Grimmer Harald Hampel Lucrezia Hausner Sabine Hellwig Sanna‐Kaisa Herukka Peter Johannsen Aleksandra Klimkowicz‐Mrowiec Sebastian Köhler Norman Koglin Koen Van Laere Mony J. de Leon Viviana Lisetti Wolfgang Maier Jan Marcusson Olga Meulenbroek Hanne M. Møllergård John C. Morris Arto Nordlund Gerald Novak George P. Paraskevas Gayan Perera Oliver Peters Inez H.G.B. Ramakers

Cerebral amyloid-β aggregation is an early event in Alzheimer disease (AD). Understanding the association between amyloid and cognitive manifestation persons without dementia important for a better understanding of course AD design prevention trials.To investigate whether associated with functioning dementia.This cross-sectional study included 2908 participants normal cognition 4133 mild impairment (MCI) from 53 studies multicenter Amyloid Biomarker Study. Normal was defined as having no...

10.1001/jamapsychiatry.2017.3391 article EN JAMA Psychiatry 2017-11-29

Our previous studies demonstrated that transplantation of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) into the hippocampus a transgenic mouse model Alzheimer's disease (AD) reduced amyloid-β (Aβ) plaques and enhanced cognitive function through paracrine action. Due to limited life span hUCB-MSCs after their transplantation, extension hUCB-MSC efficacy was essential for AD treatment. In this study, we show repeated cisterna magna injections activated endogenous...

10.1089/scd.2014.0487 article EN Stem Cells and Development 2015-07-08

Cerebrovascular disease (CVD) and Alzheimer are significant causes of cognitive impairment in the elderly. However, few studies have evaluated relationship between CVD β-amyloid burden living humans or their synergistic effects on cognition. Thus, there is a need for better understanding mild (MCI) before clinical deterioration begins.

10.1001/jamapsychiatry.2013.4506 article EN JAMA Psychiatry 2014-02-19

Brain age estimation from anatomical features has been attracting more attention in recent years. This interest brain is motivated by the importance of biological prediction health informatics, with an application to early neurocognitive disorders. It well-known that normal aging follows a specific pattern, which enables researchers and practitioners predict human's its degeneration. In this paper, we model predicted cortical thickness data gathered large cohort images. We collected 2,911...

10.3389/fnagi.2018.00252 article EN cc-by Frontiers in Aging Neuroscience 2018-08-22

In Alzheimer's continuum (a comprehensive of preclinical disease [AD], mild cognitive impairment [MCI] due to AD, and AD dementia), dysfunctions are often related cortical atrophy in specific brain regions. The purpose this study was investigate the association between anatomical pattern neuropsychological deficits.A total 249 participants with (125 dementia, 103 MCI 21 AD) who were confirmed be positive for amyloid deposits collected from memory disorder clinic department neurology at...

10.12779/dnd.2019.18.3.77 article EN cc-by-nc Dementia and Neurocognitive Disorders 2019-01-01

Alzheimer's disease is the most common cause of dementia, and currently, there no disease-modifying treatment. Favorable functional outcomes reduction amyloid levels were observed following transplantation mesenchymal stem cells (MSCs) in animal studies.We conducted a phase I clinical trial nine patients with mild-to-moderate dementia to evaluate safety dose-limiting toxicity three repeated intracerebroventricular injections human umbilical cord blood-derived MSCs (hUCB-MSCs).We recruited...

10.1186/s13195-021-00897-2 article EN cc-by Alzheimer s Research & Therapy 2021-09-14

Individual differences in working memory relate to performance general cognitive ability. The neural bases of such individual differences, however, remain poorly understood. Here, using a data-driven technique known as connectome-based predictive modeling, we built models predict from whole-brain functional connectivity patterns. Using n-back or rest data the Human Connectome Project, significantly predicted novel individuals' 2-back accuracy. Model predictions also correlated with measures...

10.1162/jocn_a_01487 article EN Journal of Cognitive Neuroscience 2019-10-29

In a clinical setting, an individual subject classification model rather than group analysis would be more informative. Specifically, the subtlety of cortical atrophy in some frontotemporal dementia (FTD) patients and overlapping patterns among three FTD syndromes including behavioral variant (bvFTD), non-fluent/agrammatic primary progressive aphasia (nfvPPA), semantic PPA (svPPA) give rise to need for models at level. this study, we aimed classify each into one diagnostic categories...

10.1016/j.nicl.2019.101811 article EN cc-by-nc-nd NeuroImage Clinical 2019-01-01
Coming Soon ...